What is DeepIntent?
DeepIntent operates as a specialized demand-side platform (DSP) engineered to bridge the gap between healthcare data and programmatic advertising. The company provides a comprehensive suite of tools designed for smarter campaign planning, cross-channel integration, and real-time performance optimization. By utilizing real-world health data, DeepIntent enables pharmaceutical brands to execute highly targeted campaigns that adhere to strict industry compliance standards. The introduction of innovative features, such as the DeepIntent Copilot, further distinguishes the platform as a leader in the health-tech marketing space, allowing for actionable measurement and enhanced campaign efficacy in an increasingly fragmented digital landscape.
How much funding has DeepIntent raised?
DeepIntent has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in DeepIntent
PPP
Public-Private Partnership
What's next for DeepIntent?
With the successful acquisition of $350K, DeepIntent is well-positioned to accelerate its product roadmap and expand its footprint in the healthcare advertising ecosystem. The company is expected to focus on scaling its data-driven insights and enhancing its proprietary technology to meet the evolving needs of top-tier pharmaceutical clients. As the industry shifts toward more personalized and data-centric marketing strategies, DeepIntent's focus on real-world evidence and integrated campaign management will likely serve as a primary driver for sustained growth and market dominance. Future initiatives will likely prioritize the integration of advanced machine learning capabilities to further optimize patient-centric messaging and improve overall return on investment for its enterprise-level partners.
See full DeepIntent company page
